首页> 外国专利> NUTRACEUTICAL FORMULATION FOR TREATMENT OF ELEVATED CHOLESTEROL AND CARDIOVASCULAR DISEASE

NUTRACEUTICAL FORMULATION FOR TREATMENT OF ELEVATED CHOLESTEROL AND CARDIOVASCULAR DISEASE

机译：用于治疗胆固醇升高和心血管疾病的营养药物配方

页面导航

摘要
著录项
相似文献

摘要

Disclosed are compositions of matter useful for the treatment of elevated blood cholesterol. In one embodiment a nutraceutical composition is administered to a patient in need of said composition comprising of the following combination of ingredients: policosanol, niacin, guggul, garlic, cynara scolymus, red yeast rice, ginger, holy basil, L-carnitine, chromium picolinate, coenzyme Q10, pantothenic acid, grape seed extract, momordica charantia, and garcinia indica.

机译：公开了可用于治疗血胆固醇升高的物质组合物。在一个实施方案中，将营养保健组合物施用于需要所述组合物的患者，所述组合物包含以下成分的组合：聚二十烷醇，烟酸，古古勒，大蒜，c子草，红曲米，姜，圣罗勒。，左旋肉碱，吡啶甲酸铬，辅酶Q10，泛酸，葡萄籽提取物，苦瓜，和藤黄。 展开▼

著录项

公开/公告号US2014314729A1

专利类型

公开/公告日2014-10-23

原文格式PDF

申请/专利权人 CREATIVE MEDICAL HEALTH INC.;
展开▼

申请/专利号US201414251005

发明设计人 AMIT PATEL;
展开▼

申请日2014-04-11

分类号A61K36/9068;A61K31/455;A61K36/328;A61K36/88;A61K36/28;A61K36/899;A61K36/53;A61K31/205;A61K31/4402;A61K31/122;A61K31/197;A61K36/87;A61K36/42;A61K36/38;A23L1/30;A23L1/302;A61K31/047;

国家 US

入库时间 2022-08-21 16:09:14

相似文献

专利

外文文献

中文文献

1. 用于治疗或预防心血管疾病的胆固醇酯转移蛋白抑制剂和含所述抑制剂的药物组合物 [P] . 中国专利： CN113332287A . 2021-09-03

2. 用于治疗或预防心血管疾病的胆固醇酯转移蛋白抑制剂和含所述抑制剂的药物组合物 [P] . 中国专利： CN113332288A . 2021-09-03

3. compound, process for preparing a compound, pharmaceutical formulation, use of a compound, methods of treating and / or preventing lipid disorders (dyslipidemia) associated or not with insulin resistance, and atherosclerosis, methods of treatment and / or prophylaxis of cardiovascular disease, hypercholesterolemia, conditions associated with the need to improve reverse cholesterol transport, and to decrease cholesterol absorption in the intestine, to increase HDL cholesterol levels, to lower cholesterol levels. ldl, inflammatory conditions, alzheimer's disease, type 2 diabetes arteriosclerosis, conditions associated with the need to improve hdl function, and pharmaceutical composition [P] . BRPI0412472A . 2006-09-19

机译：化合物，化合物的制备方法，药物制剂，化合物的用途，治疗和/或预防与胰岛素抵抗相关或不相关的脂质疾病（血脂异常）和动脉粥样硬化的方法，心血管疾病，高胆固醇血症的治疗和/或预防方法与需要改善胆固醇逆向转运，减少肠内胆固醇吸收，增加HDL胆固醇水平，降低胆固醇水平相关的疾病。 ldl，炎性疾病，阿尔茨海默氏病，2型糖尿病动脉硬化，与需要改善hdl功能相关的疾病以及药物成分

4. COMPOSITIONS, USES AND METHODS FOR TREATMENT AND/OR PREVENTION OF ELEVATED CHOLESTEROL, HYPERCHOLESTEROLEMIA, AND CARDIOVASCULAR DISEASE [P] . US2021213090A1 . 2021-07-15

机译：用于治疗和/或预防升高的胆固醇，高胆固醇血症和心血管疾病的组合物，用途和方法

5. COMPOSITIONS, USES AND METHODS FOR TREATMENT AND/OR PREVENTION OF ELEVATED CHOLESTEROL, HYPERCHOLESTEROLEMIA, AND CARDIOVASCULAR DISEASE [P] . 世界知识产权组织专利： WO2020016811A1 . 2020-01-23

机译：胆固醇升高，胆固醇过高和心血管疾病的治疗和/或预防的组合物，用途和方法

1. The rate of patients at high risk for cardiovascular disease with an optimal low-density cholesterol level: a multicenter study from Thailand [J] . Rungroj Krittayaphong, Arintaya Phrommintikul, Smonporn Boonyaratvej, 老年心脏病学杂志（英文版） . 2019,第004期

2. Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study [J] . Stephanie T.Page, Beth A.Mohr, Carol L.Link, 亚洲男性学杂志（英文版） . 2008,第002期

3. Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management [J] . Johnston T. P., Korolenko T. A., Pirro M., Pharmacological research: The official journal of The Italian Pharmacological Society . 2017,第期

4. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. [J] . Virani SS, Woodard LD, Chitwood SS, The American heart journal . 2011,第4期

5. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk [J] . Bianconi Vanessa, Mannarino Massimo Raffaele, Sahebkar Amirhossein, Current cardiology reports. . 2019,第7期

6. Development of Extracorporeal Shock Wave Therapy for the Treatment for Ischemic Cardiovascular Diseases [C] . Hiroaki Shimokawa International Symposium on Shock Waves . 2015

7. Serum lipids and statin therapy in relation to Alzheimer's disease: Exploring the relationship between elevated serum cholesterol levels and Alzheimer's disease dementia. [D] . Brinker, Krystin. 2011

8. Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study [O] . Valentina Spigoni, Raffaella Aldigeri, Monica Antonini, 1999

9. Letter by Scharnagl et al Regarding Article, “Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation” [O] . Hubert Scharnagl, Marcus E. Kleber, Winfried März 2014

1. Factors Affecting Children’s Cholesterol Levels with a View to Prevent Cardiovascular Disease—The Unique Benefits of Health Screening at the Elementary School [J] . Akihiro Kihara ,Hiromi Kawasaki ,Satoko Yamasaki . 健康（英文） . 2017,第1期

2. ACC/AHA Guidelines for Cardiovascular Disease Prevention and Cholesterol Management:Implications of New Therapeutic Agents^a [J] . Nathan D.Wong1 . 心血管创新与应用 . 2016,第B09期

3. The 2013 ACC/AHA Guidelines on Treatment of Blood Cholesterol to Improve Cardiovascular Outcomes:Implications for Statin Use and Dose vs.Target^a [J] . Sidney C.Smith1 . 心血管创新与应用 . 2016,第B09期

4. 降低成人动脉粥样硬化性心血管疾病风险的胆固醇治疗进展 [C] . . 福建省药学会药剂专业委员会2014年学术年会 . 2014

5. 升高高密度脂蛋白胆固醇药物的研究进展 [A] . 邓皓月 . 2016